SCHEMBL22155490

SCHEMBL22155490

OB(O)c1cc2ccccc2c2ccc3ccccc3c12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.48
FYN P06241 2/20 0.48
ACHE P22303 2/20 0.48
AHR P35869 2/20 0.48
ERBB2 P04626 1/20 0.48
MAOA P21397 1/20 0.48
ALDH1A1 P00352 6/20 0.48
HSD17B10 Q99714 5/20 0.48
HIF1A Q16665 3/20 0.48
CYP1B1 Q16678 2/20 0.48
HPGD P15428 4/20 0.47
MAPT P10636 2/20 0.47
HPRT1 P00492 3/20 0.46
TSHR P16473 3/20 0.44
CYP2A6 P11509 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPK1 P28482 2/20 0.44
CASP1 P29466 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31286359 1.00 CYP1A2 (0.48) CYP1A2FYNACHEAHRERBB2
SCHEMBL29628999 0.89 HSD17B10 (0.47) CYP1A2FYNACHEAHRERBB2
SCHEMBL28759609 0.89 HSD17B10 (0.47) CYP1A2FYNACHEAHRERBB2
SCHEMBL1375269 0.85 HSD17B10 (0.42) CYP1A2FYNACHEAHRERBB2
SCHEMBL29629019 0.85 HSD17B10 (0.42) CYP1A2FYNACHEAHRERBB2
SCHEMBL368234 0.80 TRPM4 (0.54) CYP1A2FYNACHEAHRERBB2
SCHEMBL29137783 0.79 CYP1A2 (0.40) CYP1A2FYNACHEAHRERBB2
SCHEMBL29137781 0.79 HPGD (0.37) CYP1A2FYNAHRALDH1A1HSD17B10
SCHEMBL1816278 0.79 CYP1A2 (0.65) CYP1A2FYNACHEAHRERBB2
SCHEMBL31286368 0.79 HPRT1 (0.58) CYP1A2FYNACHEAHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11296282-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-04-05 US disclosed
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11296282-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, EML4, SLCO2A1 CYP1A2 911/4885FYN 3992/4885ACHE 506/4885
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, EML4, SLCO2A1 CYP1A2 911/4885FYN 3992/4885ACHE 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.